Weekly Top Ten News Stories – 7 February 2025

Weekly Reports | 10:48 AM

Our top ten news from 30 January 2025 to 06 February 2025 (ranked according to popularity).

1 – Uranium Week: Tariffs & DeepSeek Worries

Tuesday 04 February 2025

January ended on a slow note as Canadian import tariffs and DeepSeek disruption concerns weighed on buyer sentiment

2 – Rudi’s View: Cochlear, Guzman y Gomez, SiteMinder, Wesfarmers & Xero

Thursday 30 January 2025

Updates on stock picker’s favourites and Model Portfolio adjustments

3 – Weekly Update On LICs & LITs – 04-Feb-2025

Tuesday 04 February 2025

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

4 – ResMed Shakes Off GLP-1 Scare

Tuesday 04 February 2025

The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry

5 – ResMed: Another Positive Quarterly Surprise?

Thursday 30 January 2025

Tomorrow’s release is expected to reveal another strong quarter from ResMed

6 – Whitehaven Coal: Sales Up, Prices Down

Friday 31 January 2025

Whitehaven Coal’s December quarter production was solid and sales surprised to the upside, but on weaker pricing

7 – Coronado Global Counts On Better Times Ahead

Thursday 30 January 2025

Following Coronado Global Resources’ fourth quarter update, analysts focus on operational improvements and upside from the Mammoth underground deposit

8 – The Market In Numbers – 1 Feb 2025

Saturday 01 February 2025

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

9 – Rudi’s View: AGL Energy, Bega Cheese, BRG, Harvey Norman, Imdex & Superloop

Thursday 06 February 2025

Updates on stock picker’s favourites and Model Portfolio adjustments

10 – FNArena Corporate Results Monitor – 05-02-2025

Wednesday 05 February 2025

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

To share this story on social media platforms, click on the symbols below.

Click to view our Glossary of Financial Terms